¼¼°èÀÇ Ä­³ªºñµð¿Ã(CBD) ½ÃÀå º¸°í¼­(2025³â)
Cannabidiol Global Market Report 2025
»óǰÄÚµå : 1775721
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,324,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,141,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,958,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ä­³ªºñµð¿Ã(CBD) ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö ³â°£ ºñ¾àÀûÀÎ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. CBD Á¦Ç°ÀÇ ¼¼°è ÇÕ¹ýÈ­¿Í ±ÔÁ¦ÀÇ Á¶È­, FDA ½ÂÀÎ CBD ÀǾàǰ ¿¬±¸ °³¹ß, Á¤½Å °Ç°­°ú ÈÞ½ÄÀ»À§ÇÑ CBD¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½É Áõ°¡, ¹Ý·Áµ¿¹° CBD ½ÃÀå°ú ¼öÀÇÇÐÀû ÀÀ¿ëÀÇ È®´ë, CBD »ý»êÀ» À§ÇÑ ´ë¸¶»ê¾÷ÀÇ È®´ë¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø±â°£¿¡ À־ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î¼­´Â ½Å±Ô CBD Àü´Þ¹æ¹ý°ú Á¦Á¦ÀÇ °³¹ß, CBD °ø±ÞüÀο¡ À־ÀÇ ºí·ÏüÀΰú ÃßÀû °¡´É¼º ¼Ö·ç¼ÇÀÇ ÅëÇÕ, ½Å±Ô CBD º£À̽º ÀǾàǰÀÇ ¿¬±¸°³¹ß¿¡ ÅõÀÚ, ¸ÂÃãÇü CBD Á¦Çü, »õ·Î¿î CBD Àü´Þ ¹æ¹ý µîÀÌ ÀÖ½À´Ï´Ù.

ÇâÈÄ 5³â°£ 34.4%ÀÇ ¼ºÀå·ü Àü¸ÁÀº ÀÌ ½ÃÀå¿¡ ´ëÇÑ ÀÌÀü ¿¹»óÄ¡º¸´Ù 0.4% ¼ÒÆø °¨¼ÒÇÑ °ÍÀ» ¹Ý¿µÇÕ´Ï´Ù. ÀÌ °¨¼Ò´Â ÁÖ·Î ¹Ì±¹°ú Ÿ±¹°£ÀÇ °ü¼¼ÀÇ ¿µÇâ¿¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù.

Á¤ºÎÀÇ ½ÂÀÎÀ» µÞ¹ÞħÇÏ´Â CBD Á¦Ç° ½ÃÀå¿¡¼­ÀÇ ¼ö¿ë°ú ÀÌ¿ëÀÇ È®´ë´Â Ä­³ªºñµð¿Ã(CBD) ½ÃÀåÀÇ È®´ë¸¦ ÃËÁøÇϴ ż¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. °¢±¹ÀÇ Á¤ºÎ´Â CBD Á¦Ç°À» ÇÕ¹ýÀûÀ¸·Î ÆÇ¸ÅÇϱâ À§ÇÑ ±ÔÁ¦°æ·Î¸¦ °³¼±ÇÏ´Â Á¶Ä¡¸¦ °­±¸Çϰí ÀÖÀ¸¸ç, ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. È£ÁÖ ½Ä¾àû(Therapeutic Goods Administration)Àº 2022³â 1¿ù ¹Ì½ÂÀÎ ÀÇ·á¿ë ´ë¸¶ÃÊ Á¦Ç°¿¡ ´ëÇØ ¾à 21¸¸ °ÇÀÇ SAS Ä«Å×°í¸® B ½ÅûÀ» ½ÂÀÎÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cannabidiol (CBD) is a chemical compound derived from the Cannabis Sativa plant, known as hemp or cannabis. It is utilized for various health conditions, including epilepsy, anxiety, dystonia, pain, Parkinson's disease, Crohn's disease, and more. Additionally, CBD is incorporated into coffee products, skincare items, and pet treats.

The primary product types of cannabidiol encompass oil, tinctures, suppositories, transdermal patches, vape oil, isolates, creams and roll-ons, capsules, tablets, and other formulations. CBD oil is formulated by extracting CBD from cannabis plants and blending it with a carrier oil like coconut or hemp seed oil. The sources of CBD include marijuana and hemp, utilized in oil and supplement production. Applications span medical, personal use, pharmaceuticals, and wellness, with distribution through channels like hospital pharmacies, retail pharmacies, online stores, and other distribution channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The escalating U.S. tariffs and rising trade tensions in spring 2025 are expected to significantly affect the chemicals sector, which is facing a disproportionate impact-particularly from tariffs on petrochemicals and intermediates, where affordable domestic alternatives are limited. Specialty chemical producers, who rely heavily on Chinese raw materials, are encountering production disruptions. Meanwhile, fertilizer manufacturers are seeing their profit margins squeezed due to tariffs on phosphate imports. In response, companies are increasing investments in R&D for bio-based alternatives, forming procurement alliances to strengthen purchasing power, and relocating production to tariff-neutral countries like Saudi Arabia.

The cannabidiol market research report is one of a series of new reports from The Business Research Company that provides cannabidiol market statistics, including cannabidiol industry global market size, regional shares, competitors with a cannabidiol market share, detailed cannabidiol market segments, market trends and opportunities, and any further data you may need to thrive in the cannabidiol industry. This cannabidiol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cannabidiol market size has grown exponentially in recent years. It will grow from $12.94 billion in 2024 to $17.63 billion in 2025 at a compound annual growth rate (CAGR) of 36.3%. The growth in the historic period can be attributed to changing regulatory environment, leading to increased legalization of cbd, growth in public awareness and acceptance of the potential health benefits of cbd, medical research supporting the use of cbd for various health conditions, emergence of diverse product categories, including cbd-infused foods, beverages, and skincare, and increased availability of cbd products through retail and e-commerce channels.

The cannabidiol market size is expected to see exponential growth in the next few years. It will grow to $57.59 billion in 2029 at a compound annual growth rate (CAGR) of 34.4%. The growth in the forecast period can be attributed to global legalization and regulatory harmonization of cbd products, pharmaceutical research and development for fda-approved cbd medications, increased consumer interest in cbd for mental health and relaxation, expansion of The pet cbd market and veterinary applications, and expansion of The hemp industry for cbd production. Major trends in the forecast period include development of novel cbd delivery methods and formulations, integration of blockchain and traceability solutions in the cbd supply chain, investment in r&d for new cbd-based pharmaceuticals, customized cbd formulations, and novel cbd delivery methods.

The forecast of 34.4% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by increasing prices for CBD isolates and extracts, heavily imported from Colombia and Canada.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing market acceptance and utilization of CBD products, fueled by government approvals, are poised to drive the expansion of the cannabidiol market. CBD, derived from Cannabis Sativa, serves as a key ingredient in various consumer products and therapeutic applications. Recognizing the potential health benefits, governments worldwide are taking measures to improve regulatory pathways for the lawful marketing of CBD products, contributing to the market's growth. An illustrative example is the Therapeutic Goods Administration in Australia, which, in January 2022, approved approximately 210,000 SAS Category B applications for unapproved medicinal cannabis products.

The anticipated rise in neurological disorders is set to be a significant driver for the cannabidiol market. Neurological disorders affecting the central and peripheral nervous systems, including the brain and spinal cord, are increasingly prevalent. Cannabis has shown promise in treating neurological conditions by regulating calcium homeostasis and reducing neuroinflammation. As reported by the Parkinson's Foundation in December 2022, the incidence rate of Parkinson's disease in the United States surged to nearly 90,000 diagnoses annually, a notable increase from previous estimates of 60,000 yearly diagnoses.

Major companies in the cannabidiol market are concentrating on product innovation, particularly in developing non-psychotropic options that do not produce psychoactive effects. Non-psychotropic refers to substances that do not influence mental processes or alter consciousness, making them suitable for medicinal use without inducing a high. For example, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical manufacturing company, launched Clasepi for epilepsy treatment. This new DCGI-approved prescription cannabidiol was introduced in India to help manage seizures related to Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients aged one year and older. This synthetic CBD product contains less than 0.1% THC, ensuring it is non-psychotropic. Clinical studies have shown its effectiveness in reducing seizures, especially when traditional antiseizure medications fail.

Major companies in the cannabidiol market are forming strategic partnerships to broaden their product offerings, enhance research and development capabilities, and strengthen their market presence. This approach allows them to provide essential communication services to individuals, businesses, and governments. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in February 2024, dsm-firmenich, a Netherlands-based chemical manufacturing company, teamed up with Zerion Pharma, a Denmark-based pharmaceutical firm. Through this collaboration, they aim to develop innovative solutions that combine DSM-Firmenich's expertise in advanced materials and formulations with Zerion Pharma's strengths in pharmaceutical development.

In December 2022, Prima, a US-based health and personal care products company, acquired Prospect Farms for an undisclosed amount. This acquisition is intended to enhance its product offerings and expand its market presence. This strategic move will incorporate Prospect Farms' expertise in high-quality hemp-derived products, reinforcing Prima's commitment to wellness and sustainability. Prospect Farms is a US-based health and wellness brand that specializes in hemp-derived products.

Major companies operating in the cannabidiol market include Endoca BV, Cannoid LLC, Medical Marijuana Inc., Folium Biosciences, Elixinol Global Limited, NuLeaf Naturals LLC, Isodiol International Inc., Pharmahemp d.o.o., Canopy Growth Corp., CV Sciences Inc., Medterra LLC, Cronos Group, CBD American Shaman LLC, Walgreens Boots Alliance, Aphria Inc., Maricann Inc., Tilray Inc., Organigram Holding Inc., CannTrust Holdings Company, Charlotte's Web Holdings Inc., Aurora Cannabis Inc., GW Pharmaceuticals PLC, Green Roads, HempMeds PX LLC, Eco Sciences, Bluebird Botanicals, HempFusion Inc., Kannaway LLC, Lazarus Naturals, Kazmira LLC, HempLife Today LLC

North America was the largest region in the cannabidiol market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabidiol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the cannabidiol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The cannabidiol market consists of sales of full spectrum CBD, broad spectrum CBD and CBD isolate forms of cannabidiol products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cannabidiol Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cannabidiol market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cannabidiol ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cannabidiol market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cannabidiol Market Characteristics

3. Cannabidiol Market Trends And Strategies

4. Cannabidiol Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cannabidiol Growth Analysis And Strategic Analysis Framework

6. Cannabidiol Market Segmentation

7. Cannabidiol Market Regional And Country Analysis

8. Asia-Pacific Cannabidiol Market

9. China Cannabidiol Market

10. India Cannabidiol Market

11. Japan Cannabidiol Market

12. Australia Cannabidiol Market

13. Indonesia Cannabidiol Market

14. South Korea Cannabidiol Market

15. Western Europe Cannabidiol Market

16. UK Cannabidiol Market

17. Germany Cannabidiol Market

18. France Cannabidiol Market

19. Italy Cannabidiol Market

20. Spain Cannabidiol Market

21. Eastern Europe Cannabidiol Market

22. Russia Cannabidiol Market

23. North America Cannabidiol Market

24. USA Cannabidiol Market

25. Canada Cannabidiol Market

26. South America Cannabidiol Market

27. Brazil Cannabidiol Market

28. Middle East Cannabidiol Market

29. Africa Cannabidiol Market

30. Cannabidiol Market Competitive Landscape And Company Profiles

31. Cannabidiol Market Other Major And Innovative Companies

32. Global Cannabidiol Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cannabidiol Market

34. Recent Developments In The Cannabidiol Market

35. Cannabidiol Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â